eSight Go™
eSight for Vision Professionals
Get Started!
Complete this form to have our eSight team connect with you about our patient referral program and clinical partnership opportunities.
"*" indicates required fields
eSight is a proven digital device for patients with central vision loss
eSight is a clinically validated, FDA- and EUDAMED-registered digital low vision Class 1 medical device designed to help your patients with significant central vision loss and legal blindness enhance their vision.
Backed by 10 years of research and development, eSight uses a compact, high-speed, high-definition camera to capture the patient’s visual field, while proprietary software algorithms optimize and enhance the footage presented to the user.¹
Conditions
eSight technology provides unprecedented improvement in a wide range of visual performance measures for more than 20 different eye conditions associated with central vision loss. eSight can immediately improve central vision for people who have moderate-to-severe visual impairment resulting from a variety of conditions, including*:
- Age-related macular degeneration
- Stargardt disease
- Myopic macular degeneration
- Diabetic retinopathy
- Cone & rod dystrophy
- And many more
* eSight may not be for patients who have dementia, glaucoma, or other neurogenerative diseases.
Clinically validated through a peer-reviewed multicenter trial
A multi-site, prospective, single-arm study that involved six recruitment centers investigated the short-and medium-term effects of eSight. With a sample size of n=51, this study primarily demonstrated:
- A seven-line gain in distance acuity
- 100% mobility retention
- 12 letter contrast improvement
- Improvement in critical print size and reading acuity
- Significant increase in facial recognition
eSight eyewear significantly improves distance acuity
Figure 1. Distance acuity equivalent of print size correctly read on the ETDRS chart at baseline without the device, at fitting with the device, and after 3 months of device use. Mean baseline acuity without device was 20/177 (mean logMAR, 0.95 [SD, 0.25]), which improved to 20/32 (mean, 0.20 [SD, 0.31]) with the device but stayed unchanged after 3 months of device use and training (mean, 0.19 [SD, 0.30]). *Statistically significant differences. ETDRS = Early Treatment Diabetic Retinopathy Study.
eSight eyewear significantly improves reading acuity
Figure 2. Reading acuity equivalent of print size read on the MNREAD chart at baseline without the device, at fitting with the device, and after 3 months of device use. Mean baseline reading acuity without device was 20/159 (mean logMAR, 0.90 [SD, 0.34]), which improved to 20/43 (mean, 0.33 [SD, 0.39]) with the device but stayed unchanged after 3 months of device use and training (mean, 0.24 [SD, 0.36]). *Statistically significant differences.
Our eQuest Partners
Restore Their Independence
Your patients are living with more than just vision loss. Provide the help your patients need to live the life they have been afraid of losing.
- Gain up to 7 lines of distance visual acuity & 12 letters of contrast¹
- Maintain mobility for independent living¹
- All day wearability—lightweight and comfortable design
- Allows users to move seamlessly through daily life
- Ability to see faces of loved ones, read books, watch TV
Experience the Ease Of eSight TeleHealth
Our eSight TeleHealth training program is designed to help patients have the best experience with their new eSight wearable device.
Patients referred to eSight Telehealth by their provider will have a virtual appointment with an eSight clinical specialist to ensure their eligibility, coordinate an in-home evaluation of the device, and provide training on how to use it. Patients will be able to use their eSight device for several days after the training session to make sure it meets their needs.
Patients who purchase the device will also be assigned a personal coach to help them as they start to use their eSight device, as well as ongoing webinars for additional tips on using your eSight device. Our coaches are users of the device themselves and can help answer questions and provide ongoing support as the patient starts to incorporate eSight into their everyday life.
The program has been proven to significantly improve patient satisfaction and quality of life through multiple peer-reviewed randomized controlled trials (RCT).
The feasibility RCT demonstrated:
- High accessibility with 93% of patients accessing the platform
- Only 14% requiring assistance from friends or family
- Minor technical issues with no cause for withdrawal
- Global acceptability with 100% overall satisfaction reported
The eSight TeleHealth training program offers a convenient and seamless patient-centered experience from referral to usage.
We make it easy to refer patients who may be able to benefit from eSight and are here to answer your questions. Click below and we’ll take care of the rest.
Testimonials
Reference:1 . Wittich, W., Lorenzini, M.-C., Markowitz, S. N., Tolentino, M., Gartner, S. A., Goldstein, J. E., & Dagnelie, G. (2018). The Effect of a Head-mounted Low Vision Device on Visual Function. Optometry and Vision Science: Official Publication of the American Academy of Optometry, 95(9), 774–784. https://doi.org/10.1097/ OPX.0000000000001262.